If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gds Regulatory News (SMSD)

Share Price Information for Samsung El.gds (SMSD)

Share Price is delayed by 15 minutes
Get Live Data
2,945.00    -240.00 (-7.54%)
Bid:
2,950.00
Ask:
2,960.00
Spread: 10.00 (0.339%)
Market Cap: $773.54b
SMSD Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gds Share Chart

  • This share is an international stock.

Transaction with Affilliate Company

31 Jul 2025 09:48

RNS Number : 3852T
Samsung Electronics Co. Ld
31 July 2025
 

Transaction with Affiliate Company

 

The Board of Directors of Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on July 31, 2025, authorized the following related-party transaction with an affiliated company.

 

Long-term loans from Samsung Display

Major transaction terms

Loan type

Long-term loans

Loan agreement date

February 16, 2023

Lender

Samsung Display

Relationship with the lender

Affiliate

Loan period

February 17, 2023-February 16, 2028

Maturity Date

February 16, 2028

Loan amount

KRW 20 trillion

Total equity of borrower as of the end of the previous business year

KRW 236,396,657 million

Percentage of loan to total equity

8.46%

Interest rate

3.90%/year

Method of loan payment

Lump sum at the maturity date (early payment is possible)

Purpose

Operational costs

Total amount of loans

(in the business year the agreement was signed)

KRW 20 trillion

Total assets of borrower as of the end of the previous business year

KRW 324,966,127 million

Percentage of loan to total assets

6.15%

Other information:

- This borrowing is intended to secure operating funds

- The above loan agreement date refers to the original agreement; and a contract extension is scheduled to be signed on August 14, 2025.

- Regarding the above interest rate, the interest rate for the original contract period (2023.02.17-2025.08.16) is 4.6% per year, and the interest rate for the extended contract period (2025.08.17-2028.02.16) is 3.9% per year

- The above 'Total amount of loans' includes the value of the loan that is the subject of this disclosure.

- The above values for total equity and total assets are from the end-2024 separate financial statements written

 in accordance with K-IFRS.

- This disclosure is a correction related to the extension of the loan agreement disclosed on February 14, 2023.

- Number of Independent Directors present at the BOD Meeting: 6 (100%)

- Attendance of Audit Committee: Y

- Date of a relevant disclosure: February 14, 2023

 

This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose financial and real estate transactions in the event the value of such a transaction is greater or equal to KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFSTDFILVIE
12
Date   Source Headline
7th Jul 20269:30 amRNSDecision on Share Disposition
7th Jul 20268:53 amRNSNotice of 2Q 2026 Earnings Release Schedule
7th Jul 20268:52 amRNS2Q 2026 Pre-Earnings Guidance
29th Jun 202610:05 amRNSFuture Business Management Plan
26th Jun 20268:23 amRNSSustainability Report 2026
25th Jun 20268:58 amRNSResponse to Rumors or Media Reports:Undetermined
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.